The story has been updated to include comments from Exact Sciences' conference call this morning.

NEW YORK (GenomeWeb News) – Exact Sciences today said that revenues for its third quarter were flat, while its net loss narrowed.

The company reported that for the three months ended Sept. 30, revenues remained at $1 million, in line with the average Wall Street estimate. All revenues were derived from licensing fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.